This excerpt taken from the ACHN 10-K filed Mar 5, 2008.
Risks Related to Our BusinessSTYLE="margin-top:18px;margin-bottom:0px">We have a limited operating history and have incurred a cumulative loss since inception. If we do not generate significant revenues, we will not be profitable.
We have incurred significant losses since our inception in August 1998. At December 31, 2007, our accumulated deficit was
To become profitable, we must successfully develop and obtain regulatory approval for our drug candidates and
cannot raise additional capital when needed, we will be unable to develop and commercialize our drug candidates successfully, and our ability to operate as a going concern may be adversely affected. STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%">We believe that our existing cash and cash equivalents will be sufficient to support our current operating plan through at least the next twelve months.
However, our operating plan may change as a result of many factors, including:
If our operating plan changes, we may need additional funds sooner than planned. Such additional
We may seek additional financing through a combination of private and public equity offerings, debt financings and